Editorial

Funding considerations for the use of experimental therapies for COVID-19 in the South African private sector

Bookmark and Share
Z Adam, R J Wiseman

Authors' affiliations

Z Adam, Medscheme Holdings (Pty) Ltd, Cape Town, South Africa

R J Wiseman, Liberty Health (Pty) Ltd, Cape Town, South Africa

Full Text

PDF (60KB)

Cite this article

South African Journal of Bioethics and Law 2020;13(2):79.

Article History

Date submitted: 2020-11-09
Date published: 2020-11-09

Article Views

Abstract views: 878
Full text views: 676

Comments on this article

*Read our policy for posting comments here